Home > Find A Specialist

Dr. Aditya Aundhakar

DrNB in Neurology

Speciality: Consultant Neurologist & Cognitive-Behavioral Sub-Specialist

Experience: 13+ years

Langauges: English, Hindi, Marathi

To Book Consultation, Call

1800-268-4000

2

Years of
Fellowship Training in Clinical & Cognitive Neurosciences

1st

Rank Honors at Bombay Neurosciences
Association (BNA)

5

Clinical Drug Trials Executed

My Patient Philosophy

To Book Consultation, Call

1800-268-4000

About Dr. Aditya Aundhakar

Dr. Aditya Chandrashekhar Aundhakar is a highly sophisticated, internationally trained Consultant Neurologist and Cognitive-Behavioral Specialist operating at the true vanguard of modern brain health and interventional neurology.

He laid his foundational medical roots at the historic Grant Government Medical College and Sir J.J. Group of Hospitals, Mumbai, followed by a residency in Internal Medicine at KIMSDU, Karad. He then secured his Doctorate in National Board (DrNB) in Neurology from the legendary Jaslok Hospital and Research Centre, Mumbai.

Driven to master the expanding frontier of neurodegenerative disease, Dr. Aundhakar completed an accredited, top-tier 2-year Clinical and Research Fellowship in Clinical and Cognitive Neurosciences at the University of Calgary, Canada.

Dr. Aundhakar’s sub-specialty expertise seamlessly connects critical emergency care with long-term neurocognitive preservation. His extensive timeline features high-volume hyperacute stroke management—including independent emergency thrombolysis pipelines—alongside specialized training in deep brain stimulation (DBS) current steering for movement disorders, electrophysiology, and advanced clinical trial protocols.

Having directly contributed to pioneering global monoclonal antibody drug trials (including lecanemab and donanemab) for Alzheimer's disease, he brings an unmatched, world-class standard of evidence-based precision back to Indian healthcare.

My Patient Philosophy:

Relying strictly on evidence-based, data-driven therapeutic protocols to demystify complex neurodegenerative, cognitive, and vascular pathways.

Cultivating an empathetic, comprehensive care architecture that proactively reduces caregiver burden while aggressively championing preventive neurology methods.

Collaborating transparently with patients and families through precision bedside testing and counseling to restore identity and functionality following stroke or cognitive decline.

Education & Board Certifications

  • DrNB (Doctorate in National Board) in Neurology: Jaslok Hospital and Research Centre, Mumbai, India (Graduated: 2022).
  • Post-Doctoral Fellowship in Clinical & Cognitive Neurosciences: University of Calgary, Alberta, Canada (Completed: 2023 – 2025).
  • MD (General Medicine): Krishna Institute of Medical Sciences "Deemed to be" University (KIMSDU), Karad, India (2015 – 2018).
  • MBBS: Grant Government Medical College & Sir J.J. Group of Hospitals, Byculla, Mumbai, India (2008 – 2013).
  • Active Medical Licensures: * Registered Medical Practitioner, Maharashtra Medical Council (Reg No. 2014/06/2870).
    1.College of Physicians & Surgeons of Alberta (CPSA) Certification as Provisional Registrar (Issued: 2023).
  • Research Accreditations: Tri-Council Policy Statement (TCPS 2: CORE 2022) Ethics Certification & CITI Program Canadian Good Clinical Practice (GCP) Stage 1 Basic Certification.

Treatment Expertise

  • Cognitive Neurology & Dementia Care
  • Comprehensive Neurodegenerative Mapping
  • Mild Behavioral Impairment (MBI) Profiling
  • Hemimasticatory & Jaw Spasm Interventions
  • Botulinum Toxin (Botox) Therapy
  • Clinical Electrophysiology
  • Electromyography (EMG)
  • Advanced Bedside Cognitive Assessment
  • Emergency Thrombolytic Pipelines
  • Cerebral Venous Thrombosis Management
  • Small Vessel Disease Management
  • Directional Deep Brain Stimulation (DBS)
  • EEG Interpretation
  • Nerve Conduction Studies (NCS)
  • Alzheimer’s Disease
  • Frontotemporal Dementia (FTD)
  • Young-Onset Neurodegenerative Syndromes
  • Behavioral & Psychiatric Symptoms of Dementia (BPSD)
  • Acute Ischemic Stroke
  • Cerebral Venous Thrombosis (CVT)
  • Small Vessel Disease
  • Cerebral Amyloid Angiopathy (CAA)
  • Parkinson’s Disease
  • Complex Dystonias
  • Hemimasticatory Spasm
  • Jaw Movement Disorders
  • Cognitive Impairment & Memory Disorders

Academic Appointments & Institutional Tenures

  • Clinical and Research Fellow: Department of Clinical Neurosciences, University of Calgary, Canada (July 2023 – June 2025).
  • Senior Resident in Neurology: Fortis Hiranandani Hospital, Vashi, Navi Mumbai, India (November 2022 – January 2024).
  • Senior Resident in General Medicine: Krishna Institute of Medical Sciences (KIMSDU), Karad, India (June 2018 – August 2019).

Global Clinical Trial Architecture

⇒Active Therapeutics Administrator & Recruiter: Formally certified and deployed across five international, multi-centric clinical drug trials at the University of Calgary, including:

 

  • Dual pioneering therapeutic protocols evaluating breakthrough monoclonal antibodies (Lecanemab & Donanemab) for structural Alzheimer's disease mitigation.
  • Targeted trial for the management of Behavioral and Psychiatric Symptoms of Dementia (BPSD).
  • Specialized trial networks tracking structural progression in Cerebral Amyloid Angiopathy and Small Vessel Disease.

Peer-Reviewed Global Publications & Manuscripts

  • Guan D, Aundhakar A, Farias S, Smith E, Ismail Z. Vascular risk factors, subjective cognitive decline, and mild behavioral impairment: A CAN-PROTECT study. Alzheimer's & Dementia, 2025;20.
  • Aundhakar A, Rajput F, Ganesh A, Ismail Z, Smith E. Correlation of Depression and Anxiety Responses on the Mild Behavioral Impairment Checklist With the Cornell Scale for Depression in Dementia and Abbreviated Version of the Penn State Worry Questionnaire. Alzheimer Disease and Associated Disorders, 2025;39:93-98.
  • Guan D, Aundhakar A, Farias S, Ballard C, Creese B, Corbett A, Pickering E, Roach P, Smith E, Ismail Z. Vascular risk factor associations with subjective cognitive decline and mild behavioral impairment. Brain Communications, 2025;7.
  • Aundhakar AC, Aundhakar SC, Mane M, Khatri MA. A Hospital based Cross Sectional Study Done to Evaluate Prevalence of Dyslipidemia in Age Group of 18-30 Years and Assess the Correlation of Dyslipidemia with Increased Waist-Hip Ratio and BMI. International Journal of Contemporary Medical Research.
  • Textbook Chapter: Ojha P, Aundhakar A, Shah A, Maniyar A. Cerebral Venous Thrombosis. Indian Academy of Neurology (Submitted/In Press).

Invited Keynotes & Major Presentations

  • The Rocky View General Hospital Oration (Calgary, June 2025): Delivered the hour-long, interdisciplinary keynote address on “Functional Cognitive Disorder”.
  • Dementia Academic Rounds (University of Calgary, 2024): Delivered advanced virtual lecture series on “Menopause and Cognition” and “Functional Cognitive Decline (FCD)”.
  • MDS Conference 2022 (Madrid, Spain): Presented the international poster on “A study of seven patients with hemimasticatory spasms: Barriers to treatment and outcomes of botulinum toxin”.
  • World Stroke Awareness Day (Mumbai, 2023): Guest speaker on “Thalamic Stroke Syndromes” at Wockhardt Hospital.

Honors, Recognitions & Research Awards

  • 1st Place Winner (BNA 2020): Awarded top honor by the Bombay Neurosciences Association for the presentation “Odd Jaw Spasms”.
  • 1st Place Winner (BNA December 2020): Awarded top honor for “Unusual cause of different strokes – scarier than the strokes itself”.
  • 2nd Place Winner (BNA 2021): Awarded for the operational study “Current steering in DBS: An Indian Experience”.
  • 2nd Place Winner (KAPICON 2018): Awarded at the Association of Physicians of India Conference for “A rare presentation of bullous pemphigoid and alkaptonuria”.
  • National & State Scholar: Decorated National Talent Search Exam (NTSE) Scholar (2006) and two-time Maharashtra Talent Search Exam Scholar (2004, 2005).